Skip to main content
Peter MacCallum Cancer Centre
  • Donate
  • Location
  • Search
  • English
  • Easy English
  • العَرَبِيَّة Arabic
  • 中文 Chinese
  • Eλληνικά Greek
  • हिन्दी Hindi
  • Italiano Italian
  • Tagalog Tagalog
  • Türkçe Turkish
  • Tiếng Việt Vietnamese
  • About
  • Profiles
  • Careers
  • Education
  • News
  • Events
  • Get involved
  • Contact
  • Cancer types
    • Breast
    • Upper Gastrointestinal
    • Lower Gastrointestinal
    • Genitourinary Oncology
    • Gynae-oncology
    • Clinical Haematology
    • Head & neck
    • Lung
    • Melanoma & Skin
    • Neuro-oncology
    • Paediatric
    • Sarcoma
    • Cancer of unknown primary
  • Our services
    • Diagnosis & investigations
    • Treatment
    • Support services
    • Cancer information & resources
  • Coming to Peter Mac
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
    • Telehealth
  • Research & discovery
    • Clinical research
    • COE in Cellular Immunotherapy
    • Research laboratories
    • Core facilities and services
    • ProsTIC
    • Research cohort studies
    • Research programs
    • Doing research with us
    • Commercialisation, partnerships and industry engagement
    • Publications
    • Education in research
    • Health Services Research
  • Clinical Trial Care
    • Patients and Families
    • Health Professionals
    • Clinical Trial Sponsors
  1. Home
  2. Profiles
  3. Assoc Prof Kaylene Simpson
Head: Victorian Centre For Functional Genomics

A/Prof Kaylene Simpson

Biography

A/Prof Kaylene Simpson heads the Victorian Centre for Functional Genomics at Peter MacCallum Cancer Centre. The VCFG enables researchers Australia-wide to perform unbiased target discovery using high throughput approaches including CRISPR, RNAi and compound screening in both 2D and 3D, underpinned by sophisticated cell phenotyping using high content imaging. Kaylene also heads a quantitative protein expression profiling platform using Reverse Phase Protein Array technology. 

Kaylene is a molecular cell biologist who specialised in breast cancer invasion and metastasis while a postdoctoral fellow at Harvard Medical School. She leads a highly experienced team who actively engage with researchers to help drive their research projects to fruition. She has a wealth of experience in assay development, data interpretation and analysis in the area of functional genomics and contributes intellectually to all projects and technology initiatives. She collaborates extensively both within Peter Mac and nationally and provides active grant support. She coordinates an annual national conference on Functional High Throughput Technologies, is a founding member and past President of the Society of Biomolecular Imaging and Informatics and is Senior Editor of Scientific DATA.

Related Links

  • Victorian Centre for Functional Genomics
  • ACRF translational reverse phase protein array

Qualifications

BSc (Hons), PhD, Diploma Of Management

Publications

Chan KT, Blake B, Zhu H, Kang J, Trigos AS, Madhamshettiwar PB, Diesch J, Paavolainen L, Horvath P, Hannan RD, George AJ, Sanij E, Hannan KM, Simpson KJ and Pearson RB. A functional genetic screen defines the AKT-induced senescence signaling network. Cell Death and Differentiation. 2019.

Ma X, Zhang L, Song J, Nguyen E, Lee RS, Rodgers SJ, Li F, Huang C, Schittenhelm RB, Chan H, Cheang C, Wu J, Brown KK, Mitchell CA, Simpson KJ, Daly RJ. Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation. Nature Communications. 2019

Lin HM, Nikolic I, Yang J, Castillo L, Deng N, Chan CL, Yeung NK, Dodson E, Elsworth B, Spielman C, Lee BY, Boyer Z, Simpson KJ, Daly RJ, Horvath LG, Swarbrick A. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.  Scientific Reports 2018 May 18;8(1):7820

Pearson H, Jason J, Meniel V, Fennell C, Waring P, Montgomery K, Rebello R, Macpherson A, Koushyar S, Furic L, Cullinane C, Clarkson R, Smalley M, Simpson KJ, Phesse T, Shepherd P, Humbert P, Sansom O and Phillips W. Identification of Pik3ca mutation as a genetic driver of prostate cancer that cooperates with Pten loss to accelerate progression and castration-resistant growth. Cancer Discovery 2018 Jun; 8(6):764-779

Cluse LA, Nikolic I, Knight D, Madhamshettiwar PB, Luu J, Cowley KJ, Semple T, Mir Arnau G, Shortt J, Johnstone RW and Simpson KJ (2018). A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR Screens. Methods in Molecular Biology. 1725:201-227.

Nikolic I, Elsworth B, Dodson E, Wu SZ, Gould CM, Mestdagh P, Marshall GM, Horvath LG, Simpson KJ, Swarbrock A (2017). Discovering cancer vulnerabilities using high-throughput micro-RNA screening. Nucleic Acids Research. 45(22):12657-12670

Williams SP, Odell AF, Karnezis T, Farnsworth RH, Gould CM, Li J, Paquet-Fifield S, Harris NC, Walter A, Gregory JL, Lamont SF, Liu R, Takano EA, Nowell CJ, Bower NI, Resnick D, Smyth GK, Coultas L, Hogan Bm, Fox SB, Mueller SN, Simpson KJ, Achen MG, Stacker SA (2017). Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodeling. Science Signaling. 10(499)

Manent J, Banerjee S, de Matos Simoes R, Zoranovic T, Mitsiades C, Penninger JM, Simpson KJ, Humbert PO, Richardson HE (2017). Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species. Oncogene. 36(40):5576-5592

Haqshenas G, Wu J, Simpson, KJ, Daly RJ, Netter HJ, Baumert TF, Doerig C (2017). Signalome-wide assessment of host cell response to hepatitis C virus. Nature Communications. 8:15158

Williams SP, Gould CM, Nowell CJ, Karnezis T, Achen MG, Simpson KJ, Stacker SA (2017). Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology. Scientific Data. 4:170009

Foo CH, Rootes CL, Cowley K, Marsh GA, Gould CM, Deffrasnes C, Cowled CJ, Klein R, Riddell SJ, Middleton D, Simpson KJ, Wang LF, Bean AG, Stewart CR (2016). Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion. PLoS Pathogens. 12(10):e1005974

Smith LK, Thomas DW, Simpson KJ, Humbert PO (2016). A Phenotypic High-Content Screening Assay to Identify Regulators of Membrane Protein Localization. Assay and Drug Development Technology. 14(8):478-488

Falkenberg KJ, Gould CM, Luu J, Matthews GM, Simpson KJ and Johnstone RW (2016).  A genome scale siRNA screen reveals GLI1 as a novel gene regulating vorinostat sensitivity. Cell Death and Differentiation. 23(7):1209-18

Dutta B, Azhir A, Merino LH, Guo Y, Revanur S, Madhamshettiwar P, GermainRN, Smith JA, Simpson KJ, Martin SE, Beuhler E and Fraser ID (2016).  CARD: an interactive web-based application for Comprehensive Analysis of RNAi-screen Data. Nature Communications.23;7:10578

Telford B, Chen A, Beethan H, Frick J, Brew T, Gould CM, Single A, Godwin T, Simpson KJ and Guilford P (2015).  Synthetic lethal screens identify vulnerabilities in GPCR signalling and cytoskeletal organisation in E-cadherin-deficient cells. Molecular Cancer Therapeutics.14(5):1213-23

Kaylene Simpson's complete list of publications

Head: Victorian Centre For Functional Genomics

A/Prof Kaylene Simpson

Peter MacCallum Cancer Centre

  • Victorian Comprehensive Cancer Centre building
    305 Grattan Street
    Melbourne VIC 3000
    Australia
    Peter MacCallum Cancer Centre
  • (03) 8559 5000 (In an emergency, call 000)
  • (03) 8559 7379 (Main fax)
  • (03) 8559 7371 (Referrals fax)
  • Locations
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
  • About us
    • Get involved
    • Upcoming events
    • Partnerships
    • Patient charter
  • Cancer types
  • Cancer services
    • Diagnosis & investigations
    • Treatments
    • Cancer info & resources
  • Refer your patient
  • Peter MacCallum Cancer Foundation
  • Australian Cancer Survivorship Centre
  • Research & discovery
    • Clinical research & trials
    • Research cohort studies
    • Research labs
  • Careers
  • Education

Our Community

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Contact us
Comments & feedback

The Peter MacCallum Cancer Centre acknowledges the traditional owners of the land on which our five sites are located throughout Victoria. We recognise their strength and resilience and pay our respects to their Elders past and present.

Languages
Auslan
Interpreter
Site by Icon Agency
  • Privacy policy
  • Terms & Conditions
  • Intranet